Keywords: inducible nitric oxide synthase kobophenol A nitric oxide nuclear factor-κB pro-inflammatory cytokines A B S T R A C T Kobophenol A (KPA) is a biologically active natural compound isolated from the roots of Caragana sinica (Buc'hoz) Rehder (C. sinica). However, the anti-inflammatory effects of KPA have not been reported. This study aims to find out whether KPA isolated from roots of C. sinica can act as a potential substance on inflammation and analyze the molecular mechanism using the lipopolysaccharide (LPS)-stimulated J774 A.1 macrophage cell line. We showed that KPA treatment significantly suppressed the production of nitric oxide (NO) by inhibiting inducible nitric oxide synthase (iNOS) expression in a dose-dependent manner without cytotoxicity. In the KPA also inhibited pro-inflammatory cytokine gene expression and production, such as interleukin-1β (IL-1β) and interleukin-6 (IL-6) in LPS-stimulated J774 A.1 cells. As continuing study on the mechanisms involved, we confirmed that these effects of KPA were related to the inhibition of nuclear factor-κB (NF-κB) pathway including the suppression of IκB kinase α/β (IKKα/β) phosphorylation and translocation of NF-κB into the nucleus. Taken together, the present study is the first to demonstrate that KPA isolated from C. sinica suppresses the expression of inflammatory mediators and cytokines by inhibiting NF-κB nuclear translocation in LPS-stimulated J774 A.1 macrophages. KPA may be a potential candidate for the treatment of inflammatory diseases in the future.
Introduction
Carana sinica (Buc'hoz) Rehder (C. sinica) belongs to the genus Caragana in the family Fabaceae. Apoptotic, phytoestrogenic, neuroprotective, anti-bacterial, and anti-oxidant effects of C. sinica have been reported in [1, 2] . C. sinica contains many oligostilbenes, such as (+)-α viniferin, caraganaphenol A, miyabenol C and kobophenol A (KPA) [3] . KPA, a tetrameric stilbene, is one of the principal active compounds in C. sinica [4, 5] . Various studies have reported the apoptotic, anti-microbial and protein kinase C inhibitory activities of KPA [1, 6] .
Inflammation is a natural biological reaction to infection or injury in the human body involving activated immune cells such as monocytes and macrophages [7] . In particular, macrophages are important in the process of secretion of pro-inflammatory mediators and the host defense system [7, 8] . During the inflammatory process, inducible nitric oxide synthase (iNOS) is an important regulator and induces the release of nitric oxide (NO). Additionally, lipopolysaccharide (LPS) induces the secretion of the pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) [8] [9] [10] [11] . Mitogen-activated protein kinases (MAPKs) play and important roles in activating the nuclear factor-κB (NF-κB) complex. IκB kinase (IKK) composed of IκB kinase α (IKKα) and IκB kinase β (IKKβ) is activated in response to LPS and pro-inflammatory cytokines. In inflammatory responses, the NF-κB complex activated by IKK leads to the degradation of inhibitory κB (IκB). Then active NF-κB complexes are phosphorylated, translocated into the nucleus and bind to the promoter of pro-inflammatory gene expression such as iNOS, TNF-α, IL-1β and IL-6 [12] [13] [14] [15] [16] . Therefore, blocking the action of the NF-κB signaling pathway and pro-inflammatory cytokines is known to target treatment for inflammatory diseases.
Recently, there has been a growing interest in physiologically active substances derived from natural products that have no or fewer side 11b), 160.0 (C-11c), 159.8 (C-13b), 158.6 (C-11a, 13a), 157.7 (C-13c), 157.3 (C-11d, 13d), 157.0 (C-4a), 156.7 (C-4d), 156.4 (C-4b), 155.1 (C4c), 146.5 (C-9a), 134.7(C-9b), 138.4(C-9d), 135.3 (C-9c), 134.4 (C1a), 133.5 (C-1d), 132.6 (C-1b), 130.9 (C-1c), 127.7 (C-2d, 6d), 126.6 (C-2c, 6c), 126.2 (C-2b, 6b), 125.7 (C-2a, 6a), 123.4 (C-10c), 119.0 (C10b), 115.5 (C-3a, 5a), 114.9 (C-3d, 5d), 114.9 (3b, 5b), 114.3 (C-3c, 5c), 109.4 (C-14c), 108.3 (C-10d, 14d), 107.4 (C-14b), 105.7 (C-10a, 14a), 102.5 (C-12d), 101.1 (C-12a), 95.2 (C-12b), 94.8 (C-12c), 92.4 (C7b), 91.5 (C-7a), 84.2 (C-7d), 83.9 (C-7c), 61.2 (C-8d), 57.2 (C-8a), 51.4 (C-8c), 51.2 (C-8b); ESI-MS (negative) m/z 923 [M -H].
Cell culture conditions
J774 A.1 cells, derived from mouse monocyte-macrophages (TIB-67) and human embryonic kidney cells (HEK 293 T) were obtained American Type Culture Collection (ATCC, Manassas, VA, USA). All cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM; ATCC) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS; ATCC, Manassas, VA, USA) and 100 U/ml penicillin and 0.1 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA) in a humidified atmosphere of 5% CO 2 at 37℃. . PCR cycling conditions were 5 min at 95°C followed by 25 cycles of 30 sec at 95°C, 40 sec at between 50 and 60°C, 1 min at 72°C and final extension for 10 min at 72°C. After amplification, PCR products were electrophoresed on 1% agarose gel containing ethidium bromide. The following primers (Bioneer Corporation, Daejeon, Republic of Korea) were used for PCR amplification: IL-1β, 5'-CTTTGAAGAAGAGCCCATCC-3' (sense) and 5'-TTTGT CGTTGCTTGGTTCTC-3' (antisense); IL-6, 5'-CACTTCACAAGTCGGAG GCTT-3' (sense) and 5'-GCAAGTGCATCATCGTTGTTC-3' (antisense); iNOS, 5'-GAGTTCGAGACTTCTGTGA-3' (sense) and 5'-GGCGATCTGG TAGTAGTAG-3' (antisense); GAPDH, 5'-CAGGTAAACTCAGGAGAGTG-3' (sense) and 5'-GTAGACTCCACGACATACT C-3' (antisense).
Cell viability assay

Western blot analysis
J774 A.1 macrophage cells were seeded in 6-well plates at a density of 4 × 10 6 cells/well and pre-treated with KPA (25-100 μM) for 1 h and then stimulated 1 μg/ml LPS for 30 min and 24 h. After incubation, cells were washed 2 times with cold PBS and harvested using RIPA buffer (Sigma Aldrich) including protease inhibitor and phosphatase inhibitors (Sigma Aldrich). 
NF-κB luciferase reporter assay
HEK 293 T cells were seeded in 24-well plates at a density of 1 × 10 5 cells/well. After overnight, the recombinant vector obtained by inserting the NF-κB gene into the pGL3-basic luciferase expression vector contained a coding region for Firefly luciferase and the pRL-SV-40 plasmid contained the cDNA encoding Renilla luciferase as a control reporter was co-transfected in DMEM, serum free media using lipofectamine (cat. no. 1857477, Invitrogen, Thermo Fisher Scientific, Inc.) for 24 h. After KPA (25-100 μM) treatment for 24 h, the cells were washed with PBS and lysed with 100 μl 1X Passive Lysis Buffer and NF-κB luciferase reporter activity was measured by a Dual Luciferase Kit (cat. no. E1910, Promega, Madison, WI, USA).
Cytosolic and nuclear proteins fraction
J774 A.1 macrophage cells were seeded in 6-well plates at a density of 1 × 10 6 cells/well and pre-treated with KPA (25-100 μM) for 1 h and then stimulated 1 μg/ml LPS for 30 min. The cells were washed 2 times with PBS and harvested. For isolation of cytosolic fractions, harvested cells were centrifuged at 12,000 × g at 4°C for 5 min and incubated on ice for 10 min in Buffer A (10 mM HEPES pH7.9, 10 mM KCl, 0.1 mM EDTA, 0.5 mM PMSF, 1 mM DTT) with 10% NP-40. The supernatant, cytosolic extract was collected by centrifugation at 12,000 × g for 2 min at 4°C. For isolation of nuclear fractions, the remaining cell pellets were resuspended and incubated on ice for 10 min in Buffer B (20 mM HEPES, 0.4 M NaCl, 1 mM EDTA, amM PMSF, amM DTT, 1% Nonidet P-40). The pellets were hardly shaked for 10 min and centrifuged at 17,000 × g at 4°C for 15 min to collect the supernatant, nuclear protein extract.
Statistical analysis
All experiments were performed in triplicate wells and triplicate experiments. Statistical analysis was determined by one-way analysis of variance (ANOVA) followed by Dunnett's test and Student's t-test between control and treated groups. All data were expressed as the means ± standard deviation (SD). Values of P < 0.05 were indicated to be statistically significant (*P < 0.05). 
Results
Effects of KPA on cell viability and NO production in LPS-stimulated J774 A.1 cells
The chemical structure of KPA isolated from the roots of C. sinica is shown in Fig. 1A . To determine the effect of KPA on cell viability in LPS-stimulated J774 A.1 cells by MTT assay, cells were treated with different concentrations of KPA (3.125-100 μM) for 1 h prior to 1 μg/ml LPS stimulation for 24 h. KPA did not change cell viability at all concentrations up to 100 μM KPA. Therefore, these results suggest that KPA has no effect on the viability of J774 A.1 cells (Fig. 1B) . We examined the inhibitory effect of KPA on NO production in LPS-stimulated J774 A.1 cells by using Griess reagent. Cells were treated with different concentrations of KPA (3.125-100 μM) for 1 h prior to 1 μg/ml LPS stimulation for 24 h. As shown in Fig. 1C , KPA dramatically inhibited NO production in a dose-dependent manner in LPS-stimulated inflammatory response in J774 A.1 cells. In particular, 50 and 100 μM KPA treatment reduced LPS-stimulated NO production by 65% and 78%, respectively. The results observed following treatment with 100 μM KPA were similar to those after treatment with 100 μM 1400 W dihydrochloride, an inhibitor of NO synthase [20] . Therefore, these results indicate that KPA has an anti-inflammatory effect through the suppression of NO production without cytotoxicity in LPS-stimulated J774 A.1 cells. [21] . We examined the effect of KPA on iNOS activity by RT-PCR and western blotting at the gene and protein level. As shown in Fig. 2A , KPA treatment (25-100 μM) significantly inhibited iNOS expression in a dose-dependent manner at mRNA level in LPS-stimulated J774 A.1 cells. We also showed that iNOS protein production was significantly inhibited by treatment with 25, 50, and 100 μM KPA (Fig. 2B) . This effect of KPA on the protein expression of iNOS was similar to that of its inhibition of the mRNA expression of iNOS ( Fig. 2A and B) . This finding suggests that KPA inhibits LPS-stimulated NO production by downregulating iNOS expression in J774 A.1 cells.
Effect of KPA on the expression of iNOS in LPS-stimulated J774 A.1 cells
NO production in LPS-stimulated J774 A.1 cells is mediated by iNOS
Effect of KPA on expression of pro-inflammatory cytokines in LPSstimulated J774 A.1 cells
Pro-inflammatory cytokines such as IL-1β and IL-6 are released through LPS stimulation in macrophage cells [22, 23] . To examine the effect of KPA on pro-inflammatory cytokine expression, we investigated the effect of KPA on IL-1β and IL-6 at the mRNA and protein levels in LPS-stimulated J774 A.1 cells. As shown in Fig. 3A , treatment with 100 μM KPA inhibited the expression of IL-1β and IL-6 at the mRNA level. Furthermore, we confirmed the effect of KPA on their protein releases by using ELISA. The production of IL-1β and IL-6 significantly reduced after treatment with KPA (25-100 μM) (Fig. 3B) . These findings also indicate that KPA has an anti-inflammatory effect by inhibiting pro-inflammatory cytokines expression.
Effect of KPA on NF-κB transcriptional activity in HEK 293 T cells
NF-κB is known to play a crucial role in regulating cell growth, differentiation and the expression of inflammatory factors such as IL-1β, IL-6 and iNOS [24, 25] . To determine the pharmacological roles and molecular mechanism of KPA on LPS-stimulated inflammatory response, we performed a reporter assay of NF-κB transcriptional activity after KPA treatment in HEK 293 T cells. We examined the reduction of NF-κB activity using 293 T cells which are sensitive to lentivirus infection [26] . Cells exposed to KPA treatment significantly decreased NF-κB transcriptional activity in a dose-dependent manner in HEK 293 T cells (Fig. 4) . (consisting of IKKα and IKKβ) is known to be related to IκB phosphorylation and signal transduction to NF-κB [27] . As shown in Fig. 5A , LPS stimulation for 30 min dramatically induced the phosphorylation of IKKα/β in the cytosolic compartments. However, KPA treatment dosedependently inhibited LPS-stimulated phosphorylation of IKKα/β in J774 A.1 cells. We investigated whether KPA regulates the translocation of NF-κB into the nucleus in LPS-stimulated J774 A.1 cells. LPS stimulation for 30 min induced the nuclear localization of NF-κB in the nuclear compartments, and KPA treatment inhibited LPS-induced nuclear localization of NF-κB p65 and p50 in a dose-dependent manner (Fig. 5B ). These results demonstrate that KPA can modulate the LPSstimulated inflammatory response by suppressing the NF-κB signaling pathway in J774 A.1 cells.
Discussion
In inflammation processes, macrophages and monocytes play a crucial role in maintaining homeostasis and the host defense system. The expression of pro-inflammatory mediators and cytokines is directly related to the inordinate inflammation response and pathogenesis of chronic diseases [28] . Nonsteroidal anti-inflammatory drugs (NSAIDs) are the generally used anti-inflammatory drugs; however, they have been known to induce side effects and lead to various other diseases [29] . Recently, there has been an increased interest in the development of new medicines from natural products with few side effects.
Inflammatory responses are regulated by pro-inflammatory mediator, NO, which is a useful target for inhibition of inflammatory symptoms. NO production in macrophages is primary regulated by iNOS in the inflammatory response [30, 31] . In our previous study, we observed that the ethanol extract of C. sinica inhibits NO production in LPS-stimulated J774 A.1 cells (data not shown). Therefore, in the present study, we isolated KPA from the ethanol extract of C. sinica and examined its effect on inflammatory response by using J774 A.1 macrophages. We showed that KPA treatment inhibits NO production and iNOS expression without cytotoxicity ( Fig. 1 and 2 ). To evaluate NO response, we used 1400 W dihydrochloride, which is a positive control for the inhibition of NO synthase, and its inhibitory effect was very similar to the effect of KPA treatment (100 μM). These results provide evidence that KPA suppresses LPS-stimulated NO production via downregulating iNOS expression in macrophages.
We also showed that KPA inhibits the release of pro-inflammatory cytokines such as IL-1β and IL-6 in LPS-stimulated J774 A.1 cells (Fig. 3) . Previous studies reported that LPS-stimulated macrophages and monocytes were able to activate and generate IL-1β and IL-6 [32] . These pro-inflammatory cytokines have critical roles in regulating inflammation response via activation of NF-κB and MAPKs [33, 34] .
NF-κB is a major transcription factor in intercellular signaling pathways, regulates inflammatory gene expression, and is induced by LPS stimulation. NF-κB is composed of the subunits p65 and p50, which are bound to IκB in the cytoplasm in the un-stimulated condition. In condition of LPS stimulation, IκB is phosphorylated by IKK [27, 35] . In this study, we observed that KPA suppresses NF-κB transcriptional activity in HEK 293 T cells (Fig. 4) . Moreover, KPA inhibited the phosphorylation of IκB kinase α/β (IKKα/β) and NF-κB translocation from the cytoplasm into the nucleus (Fig. 5) . These findings indicate that KPA suppressed pro-inflammatory mediators by blocking the nuclear translocation of NF-κB in LPS-stimulated J774 A.1 cells.
NF-κB can be activated by the LPS-stimulated activation of the MAPKs signaling pathway [36, 37] and MAPKs are important regulators in the innate and adaptive immune response [38] . In addition, inflammation related studies have been reported through animal experiments [39] [40] [41] . Therefore, further research should investigate the inhibitory effect of KPA on MAPKs related to other molecular mechanisms in animal experiments and LPS-stimulated response.
Conclusion
Taken together, these findings demonstrated that KPA isolated from the roots of C. sinica shows anti-inflammatory activity by inhibiting the expression of inflammatory mediators through the down-regulation the of NF-κB signaling pathway in LPS-stimulated J774 A.1 cells. This is the first report to show that KPA might have potential as a therapeutic agent for the regulation of inflammatory responses.
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